Gregory Alan Korbel

All filings by Gregory Alan Korbel on record concern Aprea Therapeutics, Inc., in the capacity of chief executive. Between 7 October 2019 and 28 July 2022, the trades on record add up to 19 filings.

In open-market terms, that means 1 purchase worth €6,836 on one side and 5 sales worth €471k on the other. Sales outweigh purchases by €464k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 share grants and 4 option exercises.

The record was last updated on 1 August 2022 with a share grant in Aprea Therapeutics, Inc. The clock since the last published purchase (7 October 2019) now reads 2,590 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.